ZI
ZIVO Bioscience, Inc.
ZIVO · OTC
$3.50 +9.37% (+$0.30)
1M -28.89%
Market Cap $12.4M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 189.62x
P/FCF N/A
P/FFO N/A
Growth
-
N/A Book val. growth N/A
FCF growth N/A
EPS growth N/A
Profitability
12 /100
Weak FCF margin 3,790.06%
Op. margin 8,327.18%
Gross margin 32.44%
Quality
60 /100
Average ROA 1,241.30%
Asset turnover 0.15x
ROIC 194.30%
Debt
0 /100
High Int. coverage -141.10x
Current ratio 0.10x
Net debt/EBITDA N/A
Stability
44 /100
Moderate EPS volatility 10.38%
Profitable years 0
Beta 0.11x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ZIVO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
John Bernard Payne
Employees
7
Headquarters
Troy
Upcoming events
02 DEC
Earnings
Upcoming earnings report